LDR | |
01237nam a22002891a 4500 |
001 |
|
001943926 |
003 |
|
MiAaHDL |
005 |
|
20210817000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
900430s1989 enka b 10000 eng d |
015 |
⊔ |
⊔ |
‡aGB89-43224
|
020 |
⊔ |
⊔ |
‡a1853151122
‡q(pbk.)
|
035 |
⊔ |
⊔ |
‡a(MiU)990019439260106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990019439260106381
|
035 |
⊔ |
⊔ |
‡a(OCoLC)28346036
|
035 |
⊔ |
⊔ |
‡a(RLIN)MIUG90-B20976
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph001943926
|
040 |
⊔ |
⊔ |
‡aUk
‡cUk
‡dDLC
‡dCStRLIN
‡dMiU
|
050 |
1 |
4 |
‡aRC271.F55
|
082 |
0 |
4 |
‡a616.99/4061
‡219
|
245 |
0 |
0 |
‡aLeucovorin modulation of fluoropyrimidines :
‡ba new frontier in cancer chemotherapy : proceedings of a symposium sponsored by Lederle International, a division of American Cyanamid Company, held in Amsterdam, The Netherlands, 12 April, 1989 /
‡cedited by H.M. Pinedo, Y.M. Rustum.
|
260 |
⊔ |
⊔ |
‡aLondon ;
‡aNew York :
‡bRoyal Society of Medicine Services,
‡c1989.
|
300 |
⊔ |
⊔ |
‡aviii, 128 p. :
‡bill. ;
‡c24 cm.
|
490 |
0 |
⊔ |
‡aInternational congress and symposium series ;
‡vno. 158
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographies.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aCancer
‡xChemotherapy
‡xCongresses.
|
650 |
⊔ |
0 |
‡aFluoropyrimidines
‡xTherapeutic use
‡xCongresses.
|
700 |
1 |
⊔ |
‡aRustum, Youcef M.
|
700 |
1 |
⊔ |
‡aPinedo, H. M.
|
CID |
⊔ |
⊔ |
‡a001943926
|
DAT |
0 |
⊔ |
‡a19901127000000.0
‡b20210817000000.0
|
DAT |
1 |
⊔ |
‡a20210926060713.0
‡b2024-02-28T18:43:32Z
|
DAT |
2 |
⊔ |
‡a2024-02-28T18:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990019439260106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015016980438
‡sMIU
‡1990019439260106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20240228
‡sgoogle
‡umdp.39015016980438
‡y1989
‡ric
‡qbib
‡tnon-US bib date1 >= 1929
|